Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsMyeloablative conditioning regimen

myeloablative conditioning regimen

Healthcare

FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

PR Newswire -
The U.S. Food and Drug Administration approved Omisirge, a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us